CIK 0000885725 · Large accelerated filer
BOSTON SCIENTIFIC CORP
Sign in to watch- Ticker
- BSX
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 042695240
- Phone
- 508-683-4000
- Business address
- 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA, 01752-1234
- Open-market buys, last 90 days
- $100,408
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$100,408. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-12 | Brennan Daniel J. EVP and CFO | Option exercise | +3,654 | 245,105 | ||
| 2025-02-12 | Brennan Daniel J. EVP and CFO | Shares withheld for taxes | −1,767 | $105.77 | $187K | 243,338 |
| 2025-02-12 | Brennan Daniel J. EVP and CFO | Option exercise · Restricted Stock Units | −3,654 | 10,963 | ||
| 2025-02-12 | Sorenson John Bradley EVP, Global Operations | Gift 10b5-1 | −2,156 | 30,682 | ||
| 2025-02-12 | Sorenson John Bradley EVP, Global Operations | Sale 10b5-1 | −6,389 | $105.06 | $671K | 24,293 |
| 2025-02-12 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Sale 10b5-1 | −13,022 | $105.06 | $1.4M | 28,454 |
| 2025-02-12 | Brennan Daniel J. EVP and CFO | Option exercise 10b5-1 | +15,087 | $16.31 | $246K | 256,538 |
| 2025-02-12 | Brennan Daniel J. EVP and CFO | Sale 10b5-1 | −15,087 | $105.07 | $1.6M | 241,451 |
| 2025-02-12 | Brennan Daniel J. EVP and CFO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,087 | 0 | ||
| 2025-02-11 | Sorenson John Bradley EVP, Global Operations | Grant or award 10b5-1 | +10,182 | 36,631 | ||
| 2025-02-11 | Sorenson John Bradley EVP, Global Operations | Shares withheld for taxes 10b5-1 | −3,793 | $105.98 | $402K | 32,838 |
| 2025-02-11 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Grant or award 10b5-1 | +23,760 | 52,214 | ||
| 2025-02-11 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Shares withheld for taxes 10b5-1 | −10,738 | $105.98 | $1.1M | 41,476 |
| 2025-02-11 | Mahoney Michael F Chairman, President & CEO | Grant or award | +130,118 | 1,682,788 | ||
| 2025-02-11 | Mahoney Michael F Chairman, President & CEO | Shares withheld for taxes | −62,915 | $105.98 | $6.7M | 1,619,873 |
| 2025-02-11 | Fitzgerald Joseph Michael EVP & Group Pres, Cardiology | Grant or award | +31,680 | 187,310 | ||
| 2025-02-11 | Fitzgerald Joseph Michael EVP & Group Pres, Cardiology | Shares withheld for taxes | −14,447 | $105.98 | $1.5M | 172,863 |
| 2025-02-11 | Butcher Arthur C EVP& Grp Pres, MedSurg & APAC | Grant or award | +20,366 | 25,868 | ||
| 2025-02-11 | Butcher Arthur C EVP& Grp Pres, MedSurg & APAC | Shares withheld for taxes | −9,847 | $105.98 | $1.0M | 16,021 |
| 2025-02-11 | Brown Vance R SVP, GC and Corp. Secretary | Grant or award | +14,708 | 53,583 |
Page 24 of 40 · 791 trades